KT Rama Rao unveiled several new projects in Genome Valley to the tune of Rupees 800 crores. The new projects are of varied nature — biosimilars manufacturing, advanced pharma and biotech R&D, formulation manufacturing and integrated turnkey lab spaces for high-tech research, signifying the large breadth of capabilities present in Genome Valley, which has emerged as Asia’s largest high innovation and life sciences cluster.
Hyderabad based GeneSys Biologics, a specialty biotech company engaged in R&D of advanced biosimilars also announced the inauguration of their state-of-the-art biotechnology manufacturing facility in Genome Valley.
GeneSys Biologics, a specialty biotech company engaged in R&D of advanced biosimilars, inaugurated their biotechnology manufacturing facility at Genome Valley.
Biosimilars are expected to be the next big growth segment within the biopharma industry.
JAMP Pharma, a Canadian company and a leader in generic pharmaceutical industry, to set up manufacturing facility at Genome Valley in Hyderabad.
